Opus Genetics, Inc. (IRD) Earnings Per Share (EPS)
Opus Genetics, Inc. (IRD) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | -$5.76 |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | -$5.28 |
| 2021-12-31 | -$3.82 |
| 2022-12-31 | $0.90 |
| 2023-12-31 | -$0.46 |
| 2024-12-31 | -$2.15 |
| 2025-12-31 | -$0.80 |
How IRD compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc. | -$0.01 |
| HROW | Harrow Inc Com | -$0.14 |
| ARVN | Arvinas Inc. | -$1.14 |
| HBIO | Harvard Bioscience Inc. | -$1.28 |
| NTRA | Natera Inc. | -$1.52 |
These are five companies in the same sector as IRD with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Opus Genetics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("IRD")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IRD | $3.61 | -2.96% | 0.41M |
| 3 | ||||
| 4 | ||||
| 5 |